Fractyl Health (GUTS) awards 22,500 stock options to board director
Rhea-AI Filing Summary
FRACTYL HEALTH, INC. director Ajay Royan received a grant of stock options covering 22,500 shares of common stock at an exercise price of $0.7318 per share as compensation for service on the board.
The options vest in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant, subject to his continued service as a non-employee director, and expire on June 9, 2036. Following this award, Royan holds 22,500 stock options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Royan Ajay
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 22,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 22,500 shares (Direct)
Footnotes (1)
- F1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
Key Figures
Option grant size: 22,500 options
Exercise price: $0.7318 per share
Post-grant holdings: 22,500 options
+1 more
4 metrics
Option grant size
22,500 options
Stock option award to director Ajay Royan
Exercise price
$0.7318 per share
Exercise price for the stock options
Post-grant holdings
22,500 options
Total options beneficially owned after transaction
Expiration date
June 9, 2036
Option expiration for this grant
Key Terms
stock option, non-employee director compensation policy, vest and become exercisable, annual meeting of stockholders
4 terms
stock option financial
"The stock option was awarded as compensation for the Reporting Person's service"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
non-employee director compensation policy financial
"pursuant to the Issuer's non-employee director compensation policy"
vest and become exercisable financial
"The stock option will vest and become exercisable in a single installment"
annual meeting of stockholders financial
"on the earlier of (i) the date of the next annual meeting of stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Ajay Royan report in this Form 4 for FRACTYL HEALTH (GUTS)?
Ajay Royan reported receiving a grant of 22,500 stock options as board compensation. The options relate to FRACTYL HEALTH common stock and were awarded under the company’s non-employee director compensation policy.
What is the exercise price of Ajay Royan’s new FRACTYL HEALTH stock options?
The options have an exercise price of $0.7318 per share. This is the price Royan would pay per share to convert the options into FRACTYL HEALTH common stock if he chooses to exercise them.
When do Ajay Royan’s FRACTYL HEALTH stock options vest?
The options vest in a single installment on the earlier of the next annual meeting of stockholders or the first anniversary of the grant date. Vesting requires Royan’s continued service on the board as a non-employee director.
When do Ajay Royan’s FRACTYL HEALTH stock options expire?
The stock options expire on June 9, 2036. After that date, any unexercised options will lapse, meaning Royan would no longer be able to purchase FRACTYL HEALTH common shares using this grant.
How many FRACTYL HEALTH options does Ajay Royan hold after this grant?
After this grant, Ajay Royan holds 22,500 stock options directly. This figure reflects the total number of options reported in this Form 4 as beneficially owned following the transaction.